CN105194376A - 鹿茸中药酒 - Google Patents
鹿茸中药酒 Download PDFInfo
- Publication number
- CN105194376A CN105194376A CN201510626876.1A CN201510626876A CN105194376A CN 105194376 A CN105194376 A CN 105194376A CN 201510626876 A CN201510626876 A CN 201510626876A CN 105194376 A CN105194376 A CN 105194376A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- cornu cervi
- cervi pantotrichum
- chinese medicinal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 240000001008 Dimocarpus longan Species 0.000 claims abstract description 9
- 235000000235 Euphoria longan Nutrition 0.000 claims abstract description 9
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 9
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 9
- 235000008434 ginseng Nutrition 0.000 claims abstract description 9
- 239000000463 material Substances 0.000 claims description 13
- 239000007788 liquid Substances 0.000 claims description 10
- 241000208340 Araliaceae Species 0.000 claims description 8
- 241000222336 Ganoderma Species 0.000 claims description 8
- 244000113306 Monascus purpureus Species 0.000 claims description 8
- 235000002322 Monascus purpureus Nutrition 0.000 claims description 8
- 229940057059 monascus purpureus Drugs 0.000 claims description 8
- 241000190633 Cordyceps Species 0.000 claims description 7
- 238000002386 leaching Methods 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 238000010298 pulverizing process Methods 0.000 claims description 3
- 238000007789 sealing Methods 0.000 claims description 3
- 238000007873 sieving Methods 0.000 claims description 3
- 238000003860 storage Methods 0.000 claims description 3
- 210000003734 kidney Anatomy 0.000 abstract description 36
- 239000008280 blood Substances 0.000 abstract description 23
- 210000004369 blood Anatomy 0.000 abstract description 23
- 230000000694 effects Effects 0.000 abstract description 20
- 230000007812 deficiency Effects 0.000 abstract description 17
- 201000010099 disease Diseases 0.000 abstract description 12
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 12
- 201000001881 impotence Diseases 0.000 abstract description 10
- 230000001856 erectile effect Effects 0.000 abstract description 6
- 230000003014 reinforcing effect Effects 0.000 abstract description 3
- 238000005728 strengthening Methods 0.000 abstract description 3
- 230000008901 benefit Effects 0.000 abstract description 2
- 240000000031 Achyranthes bidentata Species 0.000 abstract 1
- 241000382455 Angelica sinensis Species 0.000 abstract 1
- 235000002555 Citrus medica var sarcodactylis Nutrition 0.000 abstract 1
- 240000007126 Citrus medica var. sarcodactylis Species 0.000 abstract 1
- 241000675108 Citrus tangerina Species 0.000 abstract 1
- 241001289529 Fallopia multiflora Species 0.000 abstract 1
- 240000008397 Ganoderma lucidum Species 0.000 abstract 1
- 235000001637 Ganoderma lucidum Nutrition 0.000 abstract 1
- 241000096284 Gynochthodes officinalis Species 0.000 abstract 1
- 244000241838 Lycium barbarum Species 0.000 abstract 1
- 235000015459 Lycium barbarum Nutrition 0.000 abstract 1
- 235000015468 Lycium chinense Nutrition 0.000 abstract 1
- 241001248610 Ophiocordyceps sinensis Species 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 235000019996 baijiu Nutrition 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 229940026314 red yeast rice Drugs 0.000 abstract 1
- 239000000796 flavoring agent Substances 0.000 description 13
- 235000019634 flavors Nutrition 0.000 description 13
- 210000000952 spleen Anatomy 0.000 description 12
- 208000002193 Pain Diseases 0.000 description 11
- 239000003814 drug Substances 0.000 description 10
- 210000004185 liver Anatomy 0.000 description 9
- 206010011224 Cough Diseases 0.000 description 8
- 206010062717 Increased upper airway secretion Diseases 0.000 description 8
- 208000026435 phlegm Diseases 0.000 description 8
- 208000010228 Erectile Dysfunction Diseases 0.000 description 7
- 206010003549 asthenia Diseases 0.000 description 7
- 235000009508 confectionery Nutrition 0.000 description 7
- 210000004072 lung Anatomy 0.000 description 7
- 230000032683 aging Effects 0.000 description 6
- 208000006673 asthma Diseases 0.000 description 6
- 206010033557 Palpitations Diseases 0.000 description 5
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 5
- 206010022437 insomnia Diseases 0.000 description 5
- 208000006820 Arthralgia Diseases 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 4
- 208000025747 Rheumatic disease Diseases 0.000 description 4
- 208000031975 Yang Deficiency Diseases 0.000 description 4
- 230000036528 appetite Effects 0.000 description 4
- 235000019789 appetite Nutrition 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 238000009826 distribution Methods 0.000 description 4
- 208000002173 dizziness Diseases 0.000 description 4
- 230000027939 micturition Effects 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 230000000552 rheumatic effect Effects 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 239000000052 vinegar Substances 0.000 description 4
- 235000021419 vinegar Nutrition 0.000 description 4
- 241000251468 Actinopterygii Species 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 210000001015 abdomen Anatomy 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 210000003127 knee Anatomy 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000002035 prolonged effect Effects 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 230000035922 thirst Effects 0.000 description 3
- CTLHVAJHBQEARJ-UHFFFAOYSA-N 6-(2-chloroethyl)-4-hydroxy-2,2,5,7-tetramethyl-3h-inden-1-one Chemical compound CC1=C(CCCl)C(C)=C2C(=O)C(C)(C)CC2=C1O CTLHVAJHBQEARJ-UHFFFAOYSA-N 0.000 description 2
- YKQBHPHKXJKKAB-UHFFFAOYSA-N 6-(2-hydroxyethyl)-2,2,5,7-tetramethyl-3h-inden-1-one Chemical compound CC1=C(CCO)C(C)=CC2=C1C(=O)C(C)(C)C2 YKQBHPHKXJKKAB-UHFFFAOYSA-N 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 208000008967 Enuresis Diseases 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 206010019468 Hemiplegia Diseases 0.000 description 2
- 206010021118 Hypotonia Diseases 0.000 description 2
- 208000019255 Menstrual disease Diseases 0.000 description 2
- 208000019914 Mental Fatigue Diseases 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- OBIOZWXPDBWYHB-UHFFFAOYSA-N Nobiletin Natural products C1=CC(OC)=CC=C1C1=C(OC)C(=O)C2=C(OC)C(OC)=C(OC)C(OC)=C2O1 OBIOZWXPDBWYHB-UHFFFAOYSA-N 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- 208000009205 Tinnitus Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 238000010411 cooking Methods 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 208000017561 flaccidity Diseases 0.000 description 2
- 238000005187 foaming Methods 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 208000021267 infertility disease Diseases 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 210000000629 knee joint Anatomy 0.000 description 2
- 206010025482 malaise Diseases 0.000 description 2
- 201000004792 malaria Diseases 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- MRIAQLRQZPPODS-UHFFFAOYSA-N nobiletin Chemical compound C1=C(OC)C(OC)=CC=C1C1=CC(=O)C2=C(OC)C(OC)=C(OC)C(OC)=C2O1 MRIAQLRQZPPODS-UHFFFAOYSA-N 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000002787 reinforcement Effects 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- YRCWQPVGYLYSOX-UHFFFAOYSA-N synephrine Chemical compound CNCC(O)C1=CC=C(O)C=C1 YRCWQPVGYLYSOX-UHFFFAOYSA-N 0.000 description 2
- 235000002906 tartaric acid Nutrition 0.000 description 2
- 239000011975 tartaric acid Substances 0.000 description 2
- 235000012976 tarts Nutrition 0.000 description 2
- 231100000886 tinnitus Toxicity 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- LTVBTVOAUQJJEV-UHFFFAOYSA-N 4-methylindeno[1,2-b]pyridin-5-one Chemical compound C12=CC=CC=C2C(=O)C2=C1N=CC=C2C LTVBTVOAUQJJEV-UHFFFAOYSA-N 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 201000004569 Blindness Diseases 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000208365 Celastraceae Species 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- 206010013082 Discomfort Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 206010036631 Presenile dementia Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- SEJPCEOSGYUUIK-UHFFFAOYSA-N Pterosin Z Natural products CC1=C(CCO)C(C)=CC2=C1CC(C)(C)C2 SEJPCEOSGYUUIK-UHFFFAOYSA-N 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- UVPBNPUZWAOBQX-UHFFFAOYSA-N Sarotanoside Natural products OC1C(O)C(O)C(C)OC1OC1C(OC=2C=C3OC(CC(=O)C3=C(O)C=2)C=2C=CC=CC=2)OC(CO)C(O)C1O UVPBNPUZWAOBQX-UHFFFAOYSA-N 0.000 description 1
- 235000000336 Solanum dulcamara Nutrition 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 description 1
- 230000005784 autoimmunity Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000019636 bitter flavor Nutrition 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 150000008371 chromenes Chemical class 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- APSNPMVGBGZYAJ-GLOOOPAXSA-N clematine Natural products COc1cc(ccc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 APSNPMVGBGZYAJ-GLOOOPAXSA-N 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000009429 distress Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 208000026500 emaciation Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 229940114124 ferulic acid Drugs 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- 235000001785 ferulic acid Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 201000010235 heart cancer Diseases 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 208000024348 heart neoplasm Diseases 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 description 1
- 229940025878 hesperidin Drugs 0.000 description 1
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 208000013433 lightheadedness Diseases 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- -1 n-butene acyl lactone Chemical class 0.000 description 1
- 229940105623 neo-synephrine Drugs 0.000 description 1
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 229960003684 oxedrine Drugs 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- SONNWYBIRXJNDC-VIFPVBQESA-N phenylephrine Chemical compound CNC[C@H](O)C1=CC=CC(O)=C1 SONNWYBIRXJNDC-VIFPVBQESA-N 0.000 description 1
- 208000001297 phlebitis Diseases 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 235000020995 raw meat Nutrition 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
一种鹿茸中药酒,其原料药材分别是:鹿茸30份、淫羊藿85份、狗脊85份、冬虫草60份、桂圆65份、陈皮75份、枸杞子45份、补骨脂65份、怀牛膝60份、灵芝75份、人参45份、当归45份、佛手45份、红曲140份、何首乌85份、巴戟天75份、白酒4500份;本发明所述鹿茸中药酒,本产品具有补肾壮阳、益气养血的功效,用于肾阳虚衰、精血亏损、神疲乏力、阳痿不举等症有疗效确切。
Description
技术领域
本发明涉及中药酒领域,具体涉及由中药原料与酒配伍制成的养生中药酒。本产品具有补肾壮阳、益气养血的功效,用于肾阳虚衰、精血亏损、神疲乏力、阳痿不举等症有疗效确切。
背景技术
肾虚是人体衰老的体现,老年人肾虚是衰老引起的不可抗拒的生理过程,叫生理性肾虚,而中年人出现肾虚症状就是一种未老先衰,叫病理性肾虚。专家研究认为,肾虚可以加速人的衰老,同时加速人体内免疫活性细胞的衰老;免疫细胞衰老以后,人体的自身免疫力下降,免疫细胞清除体内致病自由基的能力下降,体内自由基的含量就会急剧增加,从而导致糖尿病、高血脂、心脏病、动脉硬化、静脉炎、关节炎、过敏、早老性痴呆、冠心病及癌症等一系列疾病。对于中老年人,老化不可避免,但延缓衰老是可行的,从而达到老而不衰。对于中年人,要改变未老先衰,就应当及时补肾,改善肾虚衰老症状。中医经典《内经》有曰:“年四十则阴气自半,起居衰矣”;步入四十岁左右的中年人就如同午后的太阳,精力由充沛走向减弱,这是人的自然衰老,也是肾脏的自然衰老,每个人都要面对和经历。中医认为:肾“藏精”,主人体的生长、发育、生殖、水液代谢和纳气。故肾为人的“先天之本”、“生命之源”。由于肾中精气是构成人体生命的原始物质,是生命活动的原始动力;在肾中精气的作用下,人体逐渐生长、发育和生殖,开始人的正常生命活动。也就是说,构成人体生命的各种物质皆由肾所产生,并且在产生之后仍由肾继续供应维持其生生不息,故体内的任何一种物质之盛衰变化均与肾的强弱息息相关,身体的种种不适与“肾”也就有着直接或间接关联。
发明内容
本发明的目的在于提供一种具有补肾壮阳、益气养血的功效,用于肾阳虚衰、精血亏损、神疲乏力、阳痿不举等症有疗效确切。
本发明的技术方案:
为达到减轻疼痛、缓解症状的功效,本发明选择:鹿茸30份、淫羊藿85份、狗脊85份、冬虫草60份、桂圆65份、陈皮75份、枸杞子45份、补骨脂65份、怀牛膝60份、灵芝75份、人参45份、当归45份、佛手45份、红曲140份、何首乌85份、巴戟天75份、白酒4500份;进行组合的,以上方所选用的原料药材药性效互补,规避了药物之间配伍的相恶、相畏、相杀之选,使药物相须、相使作用显著,具有提高免疫力作用,从而能够有效用于肾阳虚衰、精血亏损、神疲乏力、阳痿不举等症有。本发明选取的原料中药材中,其功效和药理作用分别是:
鹿茸:[主治]肾虚、头晕、耳聋、目暗、阳痿、滑精、宫冷不孕、羸瘦、神疲、畏寒、腰脊冷痛、筋骨痿软、崩漏带下、阴疽不敛及久病虚损等症。
淫羊藿:味辛甘性温,归肝肾经。功能主治:补肾壮阳,祛风除湿。治阳痿不举,偏风不遂,小便淋沥,筋骨挛急,咳嗽,病后青盲,虚火牙痛,半身不遂,腰膝无力,风湿痹痛,四肢不仁。
狗脊:金毛狗脊根茎含淀粉30%左右.狗脊蕨根茎含淀粉为48.5%,并含鞣质类.狗脊含11种微量元素,其中镁、钙、钾、铝的含量较高.含蕨素R,金粉蕨素,金粉蕨素-2’-O-葡萄糖甙,金粉蕨素-2’-O-阿洛糖甙,欧蕨伊鲁甙,蕨素Z。【性味归经】苦、甘,温。归肝、肾经。【功效】祛风湿,补肝肾,强腰膝。【主治】风湿痹痛,腰膝酸软,下肢无力,尿频,遗尿,白带过多。外敷金疮止血。
桂圆:有壮阳益气、补益心脾、养血安神、润肤美容等多种功效,可治疗贫血、心悸、失眠、健忘、神经衰弱及病后、产后身体虚弱等症。【功效】:益心脾,补气血,安神。【主治】:治虚劳羸弱,失眠症,健忘,惊悸,怔忡。【中药化学成分】:果肉(干)含水分0.85%,可溶性部分79.77%、不溶性物质19.39%,灰分3.36%。可溶性物质中,有葡萄糖24.91%、蔗糖0.22%、酸类(以酒石酸计〕1.26%、含氮物(其中含腺嘌呤和胆碱)6.309%等。其他尚含有蛋白质5.6%和脂肪0.5%等。假种皮含葡萄糖26.91%,酒石酸1.26%及少量蔗糖;另含维生素B1、B2、P、C。
陈皮:陈皮含橙皮甙约8.4%,川陈皮素(nobiletin)约0。15%.另含辛弗林(对羟福林)0.28%-2。54%。【性味】苦、辛,温。【归经】归肺、脾经。【主治功效】:理气健脾,调中,燥湿,化痰。主治脾胃气滞之脘腹胀满或疼痛、消化不良。湿浊阻中之胸闷腹胀、纳呆便溏。痰湿壅肺之咳嗽气喘。用于胸脘胀满,食少吐泻,咳嗽痰多。
枸杞子:【性味】甘,平。【归经】归肝、肾经。【功能主治】滋补肝肾,益精明目。用于虚劳精亏,腰膝酸痛,眩晕耳鸣,内热消渴,血虚萎黄,目昏不明。
补骨脂:补肾助阳;纳气平喘;温脾止泻。主肾阳不足;下元虚冷;腰膝冷痛;阳痿遗精;尿频;遗尿;肾不纳气;虚喘不止;脾肾两虚;大便久泻。
怀牛膝:功能主治:败毒抗癌;活血化瘀;逐淤除痹;消炎利尿;清血消毒;散血止痛。
灵芝:性味:性温,味淡。性状:气特殊,味微苦涩。功能主治:1、心神不宁,失眠,惊悸。该品味甘性平,入心经,能补心血、益心气、安心神,故可用治气血不足、心神失养所致的心神不宁、失眠、惊悸、多梦、健忘、体倦神疲、食少等症。2、咳喘痰多。该品味甘能补,性平偏温,入肺经,补益肺气,温肺化痰,止咳平喘,常可治痰饮证,见形寒咳嗽、痰多气喘者,尤其对痰湿型或虚寒型疗效较好。3、虚劳症。该品有补养气血作用,故常用治虚劳短气、不思饮食、手足逆冷、或烦躁口干等症。
人参:【性味归经】性平、味甘、微苦,微温。归脾、肺经、心经。【功效】大补元气,复脉固脱,补脾益肺,生津止渴,安神益智。【主治】劳伤虚损、食少、倦怠、反胃吐食、大便滑泄、虚咳喘促、自汗暴脱、惊悸、健忘、眩晕头痛、阳痿、尿频、消渴、妇女崩漏、小儿慢惊及久虚不复,一切气血津液不足之症。
当归:【化学成分】含基本内酯、正丁烯酰内酯、阿魏酸、烟酸、蔗糖和多种氨基酸,以及倍半萜类化合物等。【性味归经】性温,昧甘、辛。归肝、心、脾经。【功能主治】补血活血,调经止痛,润肠通便。用于血虚萎黄、眩晕心悸、月经不调、经闭痛经、虚寒腹痛、肠燥便秘、风湿痹痛、跌扑损伤、痈疽疮疡。
佛手:性味归经:辛、苦、酸,温。归肝、脾、胃、肺经。功能主治:舒肝理气,和胃止痛,燥湿化痰。用于肝胃气滞,胸胁胀痛,胃脘痞满,食少呕吐,咳嗽痰多。
红曲:【成分】含淀粉酶、胡萝卜色烯类。【性味】甘、温,无毒。【归经】肝;脾;胃;大肠经功能主治:活血化瘀;健脾消食。主饮食积滞;脘腹胀满;赤白下痢;产后恶露不尽;跌打损伤。
何首乌:性味:苦甘涩,微温。归经:入肝、肾经。主要功效:养血滋阴;润肠通便;截疟;祛风;解毒。主血虚头昏目眩;心悸;失眠;肝肾阴虚之腰膝酸软;须发早白;耳鸣;遗精;肠燥便秘;久疟体虚;风疹瘙痒;疮痈;瘰疬;痔疮。
巴戟天:主治阳痿遗精、宫冷不孕、月经不调、少腹冷痛、风湿痹痛、筋骨痿软。
白酒:减痛:不慎将脚扭伤后,将温白酒涂于伤处轻轻,能舒筋活血,清除疼痛。去腥:手上沾有鱼虾腥味时,用少许清洗,即可去掉腥气味。除腻:在烹调脂肪较多的肉类、鱼类时,加少许白酒,可使菜肴味道鲜美而不油腻。消苦:剖鱼时若弄破苦胆,立即在鱼肚内抹一点白酒,然后用冷水冲洗,可消除苦味。减酸:烹调菜肴时,如果加醋过多,只要再往菜中倒些白酒,可减轻酸味。去泡:因长途行走或因劳动摩擦手脚起泡时,临睡前把白酒涂于起泡处,次日晨可去泡。增香:往醋中加几滴白酒和少许食盐,搅拌均匀,既能保持醋的酸味,又能增加醋香味。
本发明所述鹿茸中药酒,其原料药材分别是:鹿茸30份、淫羊藿85份、狗脊85份、冬虫草60份、桂圆65份、陈皮75份、枸杞子45份、补骨脂65份、怀牛膝60份、灵芝75份、人参45份、当归45份、佛手45份、红曲140份、何首乌85份、巴戟天75份、白酒4500份;
其制备方法;制备方法为以下步骤:步骤一)称取原料药材:鹿茸30份、淫羊藿85份、狗脊85份、冬虫草60份、桂圆65份、陈皮75份、枸杞子45份、补骨脂65份、怀牛膝60份、灵芝75份、人参45份、当归45份、佛手45份、何首乌85份、巴戟天75份;共研成细末,过筛混匀,备用;
步骤二、将步骤一)所获得的原料药材与红曲、白酒同置于罐内,于水浴中加热煮沸后,在入缸中,密封,浸泡21日;
步骤三、将步骤二)所获得的药酒浸泡21日后,滤取酒液,残渣压榨后回收残液中的酒液,合并过滤,贮瓶备用。
以上方所选用的原料药材药性效互补,规避了药物之间配伍的相恶、相畏、相杀之选,使药物相须、相使作用显著,具有提高免疫力作用。在治疗上能达到补肾壮阳、益气养血的功效,用于肾阳虚衰、精血亏损、神疲乏力、阳痿不举等症有疗效确切。临床应用时具有良好的效果。本发明中药酒的功效在临床应用当中得到了证实,基本资料如下2004-2014,门诊临床应用本发明所述中药酒对1290例体验者用;平均年龄40岁;服用方法:每日早晚饭后饮用25-35ml;连续服用25-55日后,有效或显效1100例;有效或显效的评价标准为:症状有所改善或者症状消失。
具体实施方法
本发明所述鹿茸中药酒,其原料药材分别是:鹿茸30份、淫羊藿85份、狗脊85份、冬虫草60份、桂圆65份、陈皮75份、枸杞子45份、补骨脂65份、怀牛膝60份、灵芝75份、人参45份、当归45份、佛手45份、红曲140份、何首乌85份、巴戟天75份、白酒4500份;
其制备方法为以下步骤:步骤一)称取原料药材:鹿茸30份、淫羊藿85份、狗脊85份、冬虫草60份、桂圆65份、陈皮75份、枸杞子45份、补骨脂65份、怀牛膝60份、灵芝75份、人参45份、当归45份、佛手45份、何首乌85份、巴戟天75份;共研成细末,过筛混匀,备用;
步骤二、将步骤一)所获得的原料药材与红曲、白酒同置于罐内,于水浴中加热煮沸后,在入缸中,密封,浸泡21日;
步骤三、将步骤二)所获得的药酒浸泡21日后,滤取酒液,残渣压榨后回收残液中的酒液,合并过滤,贮瓶备用。
Claims (2)
1.一种鹿茸中药酒,其特征在于:所选原料药材分别是:鹿茸30份、淫羊藿85份、狗脊85份、冬虫草60份、桂圆65份、陈皮75份、枸杞子45份、补骨脂65份、怀牛膝60份、灵芝75份、人参45份、当归45份、佛手45份、红曲140份、何首乌85份、巴戟天75份、白酒4500份。
2.根据权利要求1所述的鹿茸中药酒,其特征在于:鹿茸30份、淫羊藿85份、狗脊85份、冬虫草60份、桂圆65份、陈皮75份、枸杞子45份、补骨脂65份、怀牛膝60份、灵芝75份、人参45份、当归45份、佛手45份、何首乌85份、巴戟天75份;共研成细末,过筛混匀,备用;
步骤二、将步骤一)所获得的原料药材与红曲、白酒同置于罐内,于水浴中加热煮沸后,在入缸中,密封,浸泡21日;
步骤三、将步骤二)所获得的药酒浸泡21日后,滤取酒液,残渣压榨后回收残液中的酒液,合并过滤,贮瓶备用。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510626876.1A CN105194376A (zh) | 2015-09-23 | 2015-09-23 | 鹿茸中药酒 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510626876.1A CN105194376A (zh) | 2015-09-23 | 2015-09-23 | 鹿茸中药酒 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105194376A true CN105194376A (zh) | 2015-12-30 |
Family
ID=54942561
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510626876.1A Pending CN105194376A (zh) | 2015-09-23 | 2015-09-23 | 鹿茸中药酒 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105194376A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105505687A (zh) * | 2016-01-27 | 2016-04-20 | 广东德庆无比养生酒业有限公司 | 一种首乌巴戟酒及其制备方法 |
-
2015
- 2015-09-23 CN CN201510626876.1A patent/CN105194376A/zh active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105505687A (zh) * | 2016-01-27 | 2016-04-20 | 广东德庆无比养生酒业有限公司 | 一种首乌巴戟酒及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105250654A (zh) | 固本乌发中药酒 | |
US8715650B2 (en) | Bathing composition and method for preparing same | |
CN104873938A (zh) | 益精养血驻颜酒 | |
CN101953989A (zh) | 一种电磁波视康仪及中药组合物 | |
CN105935409A (zh) | 安神固本中药酒 | |
CN104474487A (zh) | 补脾和胃酒 | |
CN104547268A (zh) | 定神酒 | |
CN105194376A (zh) | 鹿茸中药酒 | |
CN105147814A (zh) | 健肾酒 | |
CN104873643A (zh) | 健脑补肾中药酒 | |
CN105169350A (zh) | 一种滋阴补血的中药组合物及其制备方法 | |
CN105194067A (zh) | 宁心安神中药酒 | |
CN104921242A (zh) | 一种减肥饮料及其制备方法 | |
CN105106514A (zh) | 续断中药酒 | |
CN110227142A (zh) | 一种药酒及其制备方法 | |
CN104758634A (zh) | 强筋壮骨助阳酒 | |
CN104383406A (zh) | 治疗消化不良的中药酒 | |
CN104998241A (zh) | 黄芪益气中药酒 | |
CN105106594A (zh) | 枸杞玉液酒 | |
CN104922450A (zh) | 健脾补血养颜酒 | |
CN105920293A (zh) | 枸杞骨皮药酒 | |
CN105168408A (zh) | 复方人参当归中药酒 | |
CN104857286A (zh) | 补气壮阳填精酒 | |
CN105363000A (zh) | 丹参附子药酒 | |
CN105267707A (zh) | 枸杞沉香中药酒 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20151230 |
|
WD01 | Invention patent application deemed withdrawn after publication |